Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. Imran Ghare"'
Autor:
Amir AbdelWahab, Kedar K. Aras, Rishi Arora, Latib Azeem, Ronald D. Berger, James C. Blankenship, Gerard J.J. Boink, Davide Bolignano, Dana Boucek, Tobias Brügmann, Doron Bushi, Sheena W. Chen, Vincent M. Christoffels, Michel Corban, Regazzoli Damiano, Debabrata Dash, Robert David, Antoine A.F. de Vries, Harsha D. Devalla, J. Kevin Donahue, Igor R. Efimov, Abdallah El-Sabbagh, Giannini Francesco, Ponticelli Francesco, Paul Friedman, Dirk Geerts, M. Imran Ghare, Kashish Goel, Marie José T.H. Goumans, Robert Gray, Gallone Guglielmo, Stephanie El Hajj, Jacob A Hoffman, David R. Holmes, Jr, Erik W. Holy, Richard P. Jones, II, Johanna P. Laakkonen, Alexandra Lansky, K. Benjamin Lee, Mark S Link, Baldetti Luca, Gramegna Mario, Bernhard Meier, Dr Rohit Mody, Christine L Mummery, Fabian Nietlispach, Udi Nussinovitch, Emile Nyns, Jeffrey S. Panting, Shankar P. Parajuli, Nimesh Patel, Daniël A. Pijnappels, Abhiram Prasad, T. Alexander Quinn, Claire E. Raphael, Elon Reshef, Avi Sabbag, John Sapp, Philipp Sasse, Mark J. Schneider, Hanno L. Tan, Daniela Tirziu, Amar Trivedi, Anna M.D. Végh, Chance Witt, Rose T. Yin, Seppo Ylä-Herttuala, Shanshan Zhou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::049488fd5097a89d1e16ce9f528e0dfe
https://doi.org/10.1016/b978-0-12-813704-8.00050-4
https://doi.org/10.1016/b978-0-12-813704-8.00050-4
Transcatheter aortic valve implantation (TAVI) has emerged as a preferred method of treatment for high-risk patients with severe symptomatic aortic stenosis (AS) and is a preferred alternative to surgical aortic valve replacement for patients at inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4183fb3e4e73d27681aa6507bd9371f6
https://doi.org/10.1016/b978-0-12-813704-8.00041-3
https://doi.org/10.1016/b978-0-12-813704-8.00041-3
Publikováno v:
EuroIntervention. 14:AB53-AB63
Transcatheter aortic valve implantation (TAVI) has become the preferred method of treatment for high-risk patients with severe symptomatic aortic stenosis (AS) and is a preferred alternative to surgical valve replacement for intermediate-risk patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbcb3eef0a11fc3efde43081cf7a6aa
https://doi.org/10.4244/eij-d-18-00454
https://doi.org/10.4244/eij-d-18-00454
Autor:
Chad K Park, Hemant K Joshi, Alka Agrawal, M Imran Ghare, Elizabeth J Little, Pete W Dunten, Jurate Bitinaite, Nancy C Horton
Publikováno v:
PLoS Biology, Vol 8, Iss 12, p e1000554 (2010)
SgrAI is a type IIF restriction endonuclease that cuts an unusually long recognition sequence and exhibits allosteric self-modulation of cleavage activity and sequence specificity. Previous studies have shown that DNA bound dimers of SgrAI oligomeriz
Externí odkaz:
https://doaj.org/article/fc8be480579840c180cff46a54d26e20
Publikováno v:
Circulation. Cardiovascular interventions. 11(6)
In this issue of Circulation: Cardiovascular Interventions , Kochar et al1 report important results from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Registry (stroke and cardiovascular outcomes in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07cecbe7e28b157fdd5551e2ecabb08e
https://pubmed.ncbi.nlm.nih.gov/29895600
https://pubmed.ncbi.nlm.nih.gov/29895600
Autor:
M Imran, Ghare, Jaya, Chandrasekhar, Roxana, Mehran, Vivian, Ng, Cindy, Grines, Alexandra, Lansky
Publikováno v:
JACC. Cardiovascular interventions. 12(3)
Women have historically been underrepresented in clinical trials evaluating cardiovascular devices. Existing initiatives through government agencies have made some progress, but contemporary rates of female clinical trial participation leave much roo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a3369b0a044682e25bf75a7f69aac7d
https://pubmed.ncbi.nlm.nih.gov/30732737
https://pubmed.ncbi.nlm.nih.gov/30732737
Publikováno v:
Journal of vascular surgery. 67(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2873e05f37f866aa5740646b64f0797
https://pubmed.ncbi.nlm.nih.gov/29685252
https://pubmed.ncbi.nlm.nih.gov/29685252
Autor:
Benjamin R. Schroeder, Rakesh Paul, Paul A. Zaleski, Zhiqiang Yu, Trevor C. Bozeman, Michael James Rishel, Sidney M. Hecht, Chandrabali Bhattacharya, M Imran Ghare
Publikováno v:
Journal of the American Chemical Society
The disaccharide moiety is responsible for the tumor cell targeting properties of bleomycin (BLM). While the aglycon (deglycobleomycin) mediates DNA cleavage in much the same fashion as bleomycin, it exhibits diminished cytotoxicity in comparison to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb6f3dbbcd2d47f096861b5e827db41
https://doi.org/10.1021/ja507255g
https://doi.org/10.1021/ja507255g
Autor:
Santosh Shah, Amanda P. Stiteler, M. Imran Ghare, Nancy C. Horton, Chad K. Park, Jurate Bitinaite
Publikováno v:
Biochemistry. 49:8818-8830
SgrAI is a type II restriction endonuclease that cuts an unusually long recognition sequence and exhibits allosteric self-modulation of DNA activity and sequence specificity. Precleaved primary site DNA has been shown to be an allosteric effector [Hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a0d955cbce5a147a9a85b8dff16f20c
https://doi.org/10.1021/bi100557v
https://doi.org/10.1021/bi100557v